Plasmodium vivax in the era of the shrinking P. falciparum map

RN Price, RJ Commons, KE Battle, K Thriemer… - Trends in …, 2020 - cell.com
Plasmodium vivax is an important cause of malaria, associated with a significant public
health burden. Whilst enhanced malaria-control activities have successfully reduced the …

malERA: an updated research agenda for malaria elimination and eradication

RN Rabinovich, C Drakeley, AA Djimde, BF Hall… - PLoS …, 2017 - journals.plos.org
Achieving a malaria-free world presents exciting scientific challenges as well as
overwhelming health, equity, and economic benefits. WHO and countries are setting …

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and …

F Naudet, C Sakarovitch, P Janiaud, I Cristea, D Fanelli… - Bmj, 2018 - bmj.com
Objectives To explore the effectiveness of data sharing by randomized controlled trials
(RCTs) in journals with a full data sharing policy and to describe potential difficulties …

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

WRJ Taylor, K Thriemer, L von Seidlein, P Yuentrakul… - The Lancet, 2019 - thelancet.com
Background Primaquine is the only widely used drug that prevents Plasmodium vivax
malaria relapses, but adherence to the standard 14-day regimen is poor. We aimed to …

[HTML][HTML] Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis

RJ Commons, JA Simpson, J Watson… - The American journal …, 2020 - ncbi.nlm.nih.gov
Plasmodium vivax and Plasmodium ovale form dormant liver hypnozoites that can reactivate
weeks to months following initial infection. Malaria recurrences caused by relapses are an …

Development and validation of serological markers for detecting recent Plasmodium vivax infection

RJ Longley, MT White, E Takashima, J Brewster… - Nature medicine, 2020 - nature.com
A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals
carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This …

[HTML][HTML] Plasmodium vivax–How hidden reservoirs hinder global malaria elimination

F Angrisano, LJ Robinson - Parasitology International, 2022 - Elsevier
Plasmodium vivax is the most geographically widespread human malaria parasite. Global
malaria efforts have been less successful at reducing the burden of P. vivax compared to P …

8-Aminoquinoline therapy for latent malaria

JK Baird - Clinical Microbiology Reviews, 2019 - Am Soc Microbiol
The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer
singular scientific, clinical, and public health insights. The 8-aminoquinolines brought …

The role of early detection and treatment in malaria elimination

J Landier, DM Parker, AM Thu, VI Carrara, KM Lwin… - Malaria Journal, 2016 - Springer
Falciparum malaria persists in hard-to-reach areas or demographic groups that are missed
by conventional healthcare systems but could be reached by trained community members in …

The biology of Plasmodium vivax

JH Adams, I Mueller - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading
cause of malaria outside of Africa. Although infections are seldom fatal clinical disease can …